Allergic asthma is a chronic respiratory condition characterized by airway inflammation and hyperresponsiveness, triggered by exposure to allergens. Despite advances in pharmacological interventions, many patients with allergic asthma continue to experience symptoms and rely on long-term medication use. Immunotherapy, a therapeutic approach aimed at modifying the immune response to allergens, has emerged as a promising strategy to revolutionize allergic asthma treatment. This article explores the potential of targeted immunomodulation in allergic asthma, discussing the principles of immunotherapy, its mechanisms of action, various forms of immunotherapy, and recent advancements in this field.
HTML PDFShare this article
